A multicenter phase II study of belotecan, new camptothecin analogue, in patients with previously untreated extensive stage disease small cell lung cancer.
Kim SJ, Kim JS, Kim SC, Kim YK, Kim YK, Kang JY, Yoon HK, Song JS, Lee SH, Moon HS, Kim JW, Kim KH, Kim CH, Shim BY, Kim HK.
Kim SJ, et al. Among authors: kim sc, kim yk, kim hk, kim ch, kim js, kim jw, kim kh.
Lung Cancer. 2010 Jun;68(3):446-9. doi: 10.1016/j.lungcan.2009.07.002. Epub 2009 Aug 14.
Lung Cancer. 2010.
PMID: 19683359
Clinical Trial.